Genetic testing plays a powerful role in prostate cancer care. It can identify inherited mutations—such as BRCA1 and BRCA2—that may increase cancer risk and guide both treatment decisions and screening for family members. This approach also supports cascade testing, where sons, brothers, and close relatives are offered genetic testing once a mutation is identified, helping families catch cancers earlier. In this short excerpt, Dr. Kristen Scarpato, MD, MPH, Associate Professor of Urology and Uro

31 reactions | Knowing she had an 86% of getting breast cancer, watch Lorell describe how she found the strength to make the difficult decision to have a prophylactic mastectomy to take control to lower her cancer risk and what it’s like to be on the other side of it. bit.ly/3BTPHWv #breastcancer #previvor #breastaugmentation #brca1 #brca2 #breascancerawareness | Breastcancer.org | Facebook